Emtricitabine+Tenofovir Disoproxil Fumarate

Description

This page contains brief details about the drug emtricitabine,tenofovir disoproxil fumarate, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Emtricitabine, Tenofovir disoproxil fumarate contain two active substances, Emtricitabine and Tenofovir disoproxil fumarate. These medications are a part of the standard combination therapy for HIV, known as antiretroviral therapy (ART). It is a combination drug regimen that is commonly used for the effective treatment of HIV-1 infection. When used correctly and consistently, Emtricitabine and Tenofovir disoproxil fumarate have demonstrated high efficacy in HIV treatment and prevention. It is a combination medication for treating and preventing HIV infection that received FDA approval on July 12, 2012.

Mechanism of Action of Emtricitabine+Tenofovir Disoproxil Fumarate

Emtricitabine and Tenofovir disoproxil fumarate work by inhibiting HIV replication, reducing viral load, improving immune function, and slowing the progression of HIV disease. In individuals with HIV, these medications help control the virus, maintain a low viral load, and improve overall health outcomes.

Uses of Emtricitabine+Tenofovir Disoproxil Fumarate

Emtricitabine and Tenofovir disoproxil fumarate is used to treat HIV -1 Infection.

Emtricitabine+Tenofovir Disoproxil Fumarate Dosage available To properly consume Emtricitabine and Tenofovir disoproxil fumarate, follow your healthcare provider’s instructions regarding dosage, frequency, and duration. Take it with or without food, swallowing the tablets or capsules with water. Adhere to the prescribed dosing schedule; do not alter the dosage without consulting your healthcare provider.